XML 26 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common stock
Common stock
Employee
Paid-in capital
Paid-in capital
Employee
Retained earnings (accumulated deficit)
Accumulated other comprehensive loss
Balance at beginning of year (in shares) at Dec. 31, 2020   21,755,000          
Balance at beginning of year at Dec. 31, 2020 $ 230,136 $ 218   $ 268,666   $ 424 $ (39,172)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net (loss) income 20,801         20,801  
Other Comprehensive Income (Loss), Net of Tax 5,623           5,623
Net issuance of restricted shares granted to employees (in shares)     221,000        
Net issuance of restricted shares granted to employees and directors     $ 2   $ (2)    
Performance shares issued to employees (in shares)     150,000        
Performance shares issued to employees 0   $ 1   (1)    
Stock compensation expense $ 5,204     5,204      
Net exercise of stock options (in shares) 236,325 106,000          
Net exercise of stock options $ 877 $ 1   876      
Shares effectively repurchased for required employee withholding taxes (in shares)   (214,000)          
Shares effectively repurchased for required employee withholding taxes $ (3,189) $ (2)   (3,187)      
Stock Repurchased During Period, Shares 0            
Dividends [1] $ (3,806)         (3,806)  
Balance at end of year (in shares) at Dec. 31, 2021   22,018,000          
Balance at end of year at Dec. 31, 2021 255,646 $ 220   271,556   17,419 (33,549)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net (loss) income (6,166)         (6,166)  
Other Comprehensive Income (Loss), Net of Tax (2,305)           (2,305)
Net issuance of restricted shares granted to employees (in shares)     260,000        
Net issuance of restricted shares granted to employees and directors     $ 3   (3)    
Performance shares issued to employees (in shares)     167,000        
Performance shares issued to employees 0   $ 2   (2)    
Stock compensation expense $ 3,861     3,861      
Net exercise of stock options (in shares) 60,000 25,000          
Net exercise of stock options $ 233 $ 0   233      
Shares effectively repurchased for required employee withholding taxes (in shares)   (93,000)          
Shares effectively repurchased for required employee withholding taxes $ (1,067) $ (1)   (1,066)      
Stock Repurchased During Period, Shares (597,195) (597,000)          
Stock Repurchased During Period, Value $ (6,320) $ (6)   0   (6,314)  
Dividends [1] (3,794)         (3,794)  
Balance at end of year (in shares) at Dec. 31, 2022   21,780,000          
Balance at end of year at Dec. 31, 2022 240,088 $ 218   274,579   1,145 (35,854)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net (loss) income (8,412)         (8,412)  
Other Comprehensive Income (Loss), Net of Tax 2,355           2,355
Net issuance of restricted shares granted to employees (in shares)     325,000        
Net issuance of restricted shares granted to employees and directors     $ 3   (3)    
Performance shares issued to employees (in shares)     120,000        
Performance shares issued to employees 0   $ 1   $ (1)    
Stock compensation expense 3,690            
Shares effectively repurchased for required employee withholding taxes (in shares)   (92,000)          
Shares effectively repurchased for required employee withholding taxes $ (538) $ (1)   (537)      
Stock Repurchased During Period, Shares (320,204) (320,000)          
Stock Repurchased During Period, Value $ (2,539) $ (3)   0   (2,536)  
Dividends (3,765)         (3,765)  
Balance at end of year (in shares) at Dec. 31, 2023   21,813,000          
Balance at end of year at Dec. 31, 2023 $ 230,879 $ 218   $ 277,728   $ (13,568) $ (33,499)
[1] Cash dividend declared per share of common stock, were $0.17, $0.17 and $0.17 in 2021, 2022 and 2023, respectively.